Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Kinder Morgan Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.33 (market cap $4.59B), while Kinder Morgan Inc trades at $32.25 (market cap $71.81B). The key difference: Kinder Morgan Inc is far larger — about 15.6× Definium Therapeutics Inc. Common Shares's market cap, and Kinder Morgan Inc pays a 3.66% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Kinder Morgan Inc for 150 Days on average.
| DFTX | KMI | |
|---|---|---|
Market Cap | $4.59B | $71.81B |
Volume | 2,103,937 | 16,921,908 |
Sector | Health | Energy |
52-Week High | $48.45 | $34.31 |
52-Week Low | $10.68 | $25.84 |
Typical Hold Time | 0 Days | 150 Days |
Enterprise Value | $3.55B | $103.86B |
Dividend Yield | — | 3.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kinder Morgan (KMI) trades at $31.82, down 1.06% today, with a bullish technical signal and strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters, showing revenue growth from $15.1B in 2024 to $16.9B in 2025, with net income rising to $3.06B. Analyst consensus targets $37.20, suggesting 17% upside potential, supported by a $10B project backlog and growing natural gas demand from LNG exports and data centers.
KMI presents a compelling investment case with stable fee-based revenues, dividend yield, and growth opportunities in energy infrastructure. Key risks include energy market volatility, high debt levels ($29.66B long-term debt), and interest rate sensitivity. The stock offers value with reasonable valuation multiples (P/E 20.53, P/S 3.94) and positive analyst sentiment despite competitive pressures in the midstream sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
